I-Mab to Participate at the Piper Sandler Healthcare Conference
The 36th Annual Healthcare Conference will be held in New York, December 3-5, 2024
ROCKVILLE, MD, November 21, 2024 – I-Mab (NASDAQ: IMAB, the “Company”), a U.S.-based global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the Piper Sandler 36th Annual Healthcare Conference on December 4, 2024.
Piper Sandler 36th Annual Healthcare Conference Presentation Details
| Presentation Time | Wednesday, December 4 at 4:30 p.m. ET |
| Presenters | Sean Fu, PhD, MBA, Chief Executive Officer Phillip Dennis, MD, PhD, Chief Medical Officer |
| Webcast link | Here |
| Meetings | One-on-one and small group meetings: December 3 – 4, 2024 |
| Management Participants | Sean Fu, PhD, MBA, Chief Executive Officer Joseph Skelton, Chief Financial Officer Phillip Dennis, MD, PhD, Chief Medical Officer Tyler Ehler, Senior Director, Investor Relations |
For more information, please contact your Piper Sandler representative.
About I-Mab
I-Mab (NASDAQ: IMAB) is a US-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in Rockville, Maryland, and Short Hills, New Jersey. For more information, please visit https://www.i-mabbiopharma.com and follow us on LinkedIn and X.
For more information, please contact:
Tyler Ehler
Senior Director, Investor Relations
IR@imabbio.com